Clinical Trials Browser

Phase 1/2 × INDUSTRY × temsirolimus × Clear all

NCT01111825 2018-09-26

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

Phase 1/2 Completed

99 enrolled 14 charts

Breast Neoplasms

NCT00106353 2013-02-08

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Phase 1/2 Completed

71 enrolled 42 charts

Adenocarcinoma, Neoplasms